Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gordon

Showing results (141-150 of 1,254) with videos related to

Pageof 126
Sort By:
Expert Opinion on Biological Therapy|July 25, 2014
Pidilizumab in the treatment of diffuse large B-cell lymphomaLocke J Bryan, Leo I Gordon
Clinical Advances in Hematology & Oncology : H&O|May 17, 2022
CAR T-cell therapy for relapsed/refractory non-Hodgkin's lymphoma: a comprehensive reviewFrédérique St-Pierre, Leo I Gordon
Community Health Studies|January 1, 1989
Social class as indicated by area of residence: a mortality study within an Australian industrial populationI Gordon, D Christie, K Robinson
Applied Optics|October 1, 1984
Equilibrium radiance model applications and comparisons to atmospheric measurements and Rayleigh modelsJ I Gordon, R W Johnson
Life Sciences|January 1, 1994
[3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitorsI Gordon, R Weizman, M Rehavi
The Journal of Clinical Investigation|July 3, 2023
Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphomaAdam Yuh Lin, Leo I Gordon
The Journal of Biological Chemistry|December 15, 1987
The effects of deleting the propeptide from human preproapolipoprotein A-I on co-translational translocation and signal peptidase processingR J Folz, J I Gordon
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2006
A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualismBuck S Samuel, Jeffrey I Gordon
Future Oncology (London, England)|January 18, 2023
Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphomaFrédérique St-Pierre, Leo I Gordon
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|April 7, 1999
Creating the future: rather than simply reacting to itJ I Gordon, D M Kipnis
Pageof 126

Showing results (141-150 of 1,254) with videos related to

Sort By:
Pageof 126
Expert Opinion on Biological Therapy|July 25, 2014
Pidilizumab in the treatment of diffuse large B-cell lymphomaLocke J Bryan, Leo I Gordon
Clinical Advances in Hematology & Oncology : H&O|May 17, 2022
CAR T-cell therapy for relapsed/refractory non-Hodgkin's lymphoma: a comprehensive reviewFrédérique St-Pierre, Leo I Gordon
Community Health Studies|January 1, 1989
Social class as indicated by area of residence: a mortality study within an Australian industrial populationI Gordon, D Christie, K Robinson
Applied Optics|October 1, 1984
Equilibrium radiance model applications and comparisons to atmospheric measurements and Rayleigh modelsJ I Gordon, R W Johnson
Life Sciences|January 1, 1994
[3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitorsI Gordon, R Weizman, M Rehavi
The Journal of Clinical Investigation|July 3, 2023
Discovering the fibroblastic reticular cell in the immune tumor microenvironment in lymphomaAdam Yuh Lin, Leo I Gordon
The Journal of Biological Chemistry|December 15, 1987
The effects of deleting the propeptide from human preproapolipoprotein A-I on co-translational translocation and signal peptidase processingR J Folz, J I Gordon
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2006
A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualismBuck S Samuel, Jeffrey I Gordon
Future Oncology (London, England)|January 18, 2023
Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphomaFrédérique St-Pierre, Leo I Gordon
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha|April 7, 1999
Creating the future: rather than simply reacting to itJ I Gordon, D M Kipnis
Pageof 126